bionic-pancreas | Media Room | PressRelease.com

Press Release Aug 15, 2024

Beta Bionics Celebrates Milestone: 10,000th iLet Patient

Press Release May 6, 2024

Xeris Enters Into an Exclusive Worldwide Collaboration and License Agreement With Beta Bionics

For development and commercialization of a new and unique formulation of liquid stable glucagon for use in a bi-hormonal pump and pump systems.

Press Release Dec 7, 2023

Beta Bionics Announces the Nationwide Launch of the iLet Bionic Pancreas With Dexcom G7 CGM System

Beginning Dec. 18, iLet users will have the option of using a Dexcom G7 CGM System.

Press Release Nov 14, 2023

Beta Bionics Announces iLet Bionic Pancreas Is Now Added to the Express Scripts National Commercial Formularies

Press Release Aug 30, 2023

Beta Bionics Secures $100 Million in Series D Funding to Advance Diabetes Technology and Expand Market Presence

Press Release Jun 22, 2023

Beta Bionics Announces FDA Clearance for the Use of a Prefilled Insulin Cartridge With the iLet Bionic Pancreas

Press Release May 22, 2023

Beta Bionics Announces FDA Clearance and Commercialization of the iLet Bionic Pancreas

- First and only, automated insulin-delivery system that determines 100% of all insulin doses.
- No carb counting*, no corrections, no calculating boluses.
- Only needs your body weight to get started.

Press Release Jan 4, 2023

Beta Bionics Appoints Dr. Steven Russell as Chief Medical Officer in Preparation for the Commercial Launch of the iLet Bionic Pancreas System

Caution: The iLet Bionic Pancreas is an investigational device limited by Federal law to investigational use. Not available for sale.